Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Dr. Hudis on the Link Between Obesity and Cancer

      March 3, 2015
      By Clifford A. Hudis, MD
      Video

      Clifford A. Hudis, MD, chief, Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, professor of medicine, Weill Cornell Medical College, discusses the link between obesity and cancer.

      Clifford A. Hudis, MD, chief, Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, professor of medicine, Weill Cornell Medical College, discusses the link between obesity and cancer.

      Hudis says the problem of obesity in the United States is a relatively new issue and has profound medical consequences. Many people know that obesity can lead to arthritis, diabetes and hypertension, but obesity can also cause pancreatitis, gallstones, reflux esophagitis and other ailments including cancer, Hudis says.

      Researchers have known that obesity was associated with some specific cancers, such as uterine cancer and breast cancer but they are now discovering that obesity is also associated with colon cancer and high-grade prostate cancers.

      Hudis says the reason obesity is associated with cancer is the biochemical reactions that take place when a patient is obese. There are inflammatory cellular structures within the fat tissue that produce inflammatory mediators, which activate aromatase. The activation of aromatase is associate with both breast cancer and endometrial cancer, Hudis says.​

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a woman with brown hair and bangs, surrounded by a blue border
      Photo of an open bottle of pills
      4 experts in this video
      4 experts in this video
      Photo of a woman wearing a blazer and a colorful scarf in front of a blue background
      Related Content

      Photo of a person in a bathroom holding their abdomen and mouth

      Adding Aprepitant to Chemo Extends Non-Luminal Breast Cancer Survival

      Bridget Hoyt
      August 3rd 2025
      Article

      Adding aprepitant to chemotherapy was linked to longer survival in patients with non-luminal breast cancers, especially triple-negative breast cancer.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      August 3rd 2025
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Graphic of a person with a breast tumor

      Awareness of Actionable Mutations Guides mBC Treatment Post-Endocrine

      Bridget Hoyt
      August 3rd 2025
      Article

      Understanding actionable mutations and educating patients on the safety profiles of targeted therapies are essential for the care of HR+, HER2- mBC.


      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      August 3rd 2025
      Podcast

      Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.


      Graphic of a breast with a tumor

      Olanzapine/Triplet Cuts Chemotherapy-Induced Nausea, Vomiting in Breast Cancer

      Roman Fabbricatore
      August 3rd 2025
      Article

      Those who took olanzapine reported higher levels of satisfaction than patients on placebo.


      graphic of a breast with a tumor

      KN026/KN046 Combo Yields Durable Responses in HER2+ mBC

      Jax DiEugenio
      August 3rd 2025
      Article

      KN026 plus KN046 produced sustained responses and showed a manageable safety profile in pretreated patients with HER2-positive advanced breast cancer.

      Related Content

      Photo of a person in a bathroom holding their abdomen and mouth

      Adding Aprepitant to Chemo Extends Non-Luminal Breast Cancer Survival

      Bridget Hoyt
      August 3rd 2025
      Article

      Adding aprepitant to chemotherapy was linked to longer survival in patients with non-luminal breast cancers, especially triple-negative breast cancer.


      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

      Lindsay Fischer
      August 3rd 2025
      Podcast

      Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.


      Graphic of a person with a breast tumor

      Awareness of Actionable Mutations Guides mBC Treatment Post-Endocrine

      Bridget Hoyt
      August 3rd 2025
      Article

      Understanding actionable mutations and educating patients on the safety profiles of targeted therapies are essential for the care of HR+, HER2- mBC.


      The Vitals

      Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

      Lindsay Fischer
      August 3rd 2025
      Podcast

      Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.


      Graphic of a breast with a tumor

      Olanzapine/Triplet Cuts Chemotherapy-Induced Nausea, Vomiting in Breast Cancer

      Roman Fabbricatore
      August 3rd 2025
      Article

      Those who took olanzapine reported higher levels of satisfaction than patients on placebo.


      graphic of a breast with a tumor

      KN026/KN046 Combo Yields Durable Responses in HER2+ mBC

      Jax DiEugenio
      August 3rd 2025
      Article

      KN026 plus KN046 produced sustained responses and showed a manageable safety profile in pretreated patients with HER2-positive advanced breast cancer.

      Latest Conference Coverage

      Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL

      Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts

      Proactive Rash Management Vital for PI3K, AKT Inhibition in Breast Cancer

      Understanding How On-Target and Off-Target ADC Toxicities Work

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.